A carregar...
Safinamide: an add-on treatment for managing Parkinson’s disease
Heterogeneous expression of neurotransmitter deficits results from onset and progression of Parkinson’s disease. Intervals, characterized by reappearance of motor and associated certain nonmotor symptoms, determine the end of good tolerability and efficacy of oral levodopa therapy. These “OFF” state...
Na minha lista:
| Publicado no: | Clin Pharmacol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896660/ https://ncbi.nlm.nih.gov/pubmed/29670409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S137740 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|